Company profile for Amryt Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets. A core belief at Amryt Pharma is that they operate on a foundation of responsibility, integrity, and ethical practice. They aim to forge pa...
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets. A core belief at Amryt Pharma is that they operate on a foundation of responsibility, integrity, and ethical practice. They aim to forge partnerships and collaborations that work for all. By listening to our stakeholders and most importantly our patients, they create a clear path for our transformative medicines to reach those that need them.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
45 Mespil Road, Dublin City, County Dublin D04, IE
Telephone
Telephone
+353 1518 0200
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accesswire.com/viewarticle.aspx?id=801510&lang=en

ACCESSWIRE
09 Nov 2023

https://www.globenewswire.com/news-release/2023/04/03/2639413/0/en/High-Court-of-Justice-of-England-and-Wales-Sanctions-Scheme-of-Arrangement.html

GLOBENEWSWIRE
03 Apr 2023

https://www.globenewswire.com/news-release/2023/03/22/2632434/0/en/Amryt-Pharma-Shareholders-approve-acquisition-of-Amryt-Pharma-by-Chiesi-Farmaceutici.html

GLOBENEWSWIRE
22 Mar 2023

https://www.globenewswire.com/news-release/2023/02/16/2609527/0/en/AMRYT-PUBLISHES-SCHEME-CIRCULAR-AND-ANNOUNCES-THE-SHAREHOLDER-MEETINGS-TO-CONSIDER-AND-VOTE-ON-THE-CHIESI-ACQUISITION-WILL-BE-HELD-ON-MARCH-22-2023.html

GLOBENEWSWIRE
16 Feb 2023
After Amryt buy, Chiesi names Baxter vet Accogli its new CEO
After Amryt buy, Chiesi names Baxter vet Accogli its new CEO

30 Jan 2023

// Kevin Dunleavy FIERCE PHARMA

https://www.fiercepharma.com/pharma/chiesi-fils-ceo-post-baxter-veteran-accogli-after-acquiring-amryt-15b-deal

Kevin Dunleavy FIERCE PHARMA
30 Jan 2023
Chiesi gets jump-start on JPM buzz with $1.48B Amryt buyout
Chiesi gets jump-start on JPM buzz with $1.48B Amryt buyout

09 Jan 2023

// Eric Sagonowsky FIERCE PHARMA

https://www.fiercepharma.com/pharma/chiesi-gets-jump-start-jpm-buzz-148b-amyrt-buyout

Eric Sagonowsky FIERCE PHARMA
09 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty